Form D · Biotechnology
TESSELLATE THERAPEUTICS INC
Henderson, NV · CIK 0001891542
Offering snapshot reported Nov 16, 2021 · SEC filing
- Reported sold
- $80K Offering amount: $80K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2021 | Initial | $80,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-421363
Source: Form D, filed Nov 16, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dustin Hines | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1033 Kennebunk Circle
Henderson, NV, 89015
Henderson, NV, 89015